

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 9.44992222 |
| 2 | regulation of cholesterol esterification (GO:0010872) | 8.82916957 |
| 3 | high-density lipoprotein particle remodeling (GO:0034375) | 8.59310848 |
| 4 | reverse cholesterol transport (GO:0043691) | 8.45678064 |
| 5 | phospholipid efflux (GO:0033700) | 8.07669869 |
| 6 | protein neddylation (GO:0045116) | 7.57335452 |
| 7 | plasma lipoprotein particle assembly (GO:0034377) | 7.45316859 |
| 8 | phospholipid homeostasis (GO:0055091) | 7.03554764 |
| 9 | protein-lipid complex assembly (GO:0065005) | 6.50334124 |
| 10 | protein-lipid complex remodeling (GO:0034368) | 6.42671172 |
| 11 | macromolecular complex remodeling (GO:0034367) | 6.42671172 |
| 12 | plasma lipoprotein particle remodeling (GO:0034369) | 6.42671172 |
| 13 | regulation of cytokine secretion involved in immune response (GO:0002739) | 6.25735305 |
| 14 | low-density lipoprotein particle remodeling (GO:0034374) | 5.79152072 |
| 15 | plasma lipoprotein particle organization (GO:0071827) | 5.66886445 |
| 16 | cholesterol efflux (GO:0033344) | 5.52309096 |
| 17 | protein-lipid complex subunit organization (GO:0071825) | 5.25891645 |
| 18 | negative chemotaxis (GO:0050919) | 5.13868124 |
| 19 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.98934313 |
| 20 | plasma lipoprotein particle clearance (GO:0034381) | 4.80026089 |
| 21 | negative regulation of lipase activity (GO:0060192) | 4.69963395 |
| 22 | neutral lipid catabolic process (GO:0046461) | 4.68033824 |
| 23 | acylglycerol catabolic process (GO:0046464) | 4.68033824 |
| 24 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.62829704 |
| 25 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.57897775 |
| 26 | L-ascorbic acid metabolic process (GO:0019852) | 4.44547303 |
| 27 | keratinocyte development (GO:0003334) | 4.32819951 |
| 28 | otic vesicle formation (GO:0030916) | 4.31892654 |
| 29 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.28360305 |
| 30 | sterol transport (GO:0015918) | 4.26236454 |
| 31 | cholesterol transport (GO:0030301) | 4.26236454 |
| 32 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.15370370 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 4.03725643 |
| 34 | negative regulation of sterol transport (GO:0032372) | 4.03725643 |
| 35 | negative regulation of sodium ion transport (GO:0010766) | 3.97598311 |
| 36 | triglyceride homeostasis (GO:0070328) | 3.94907301 |
| 37 | acylglycerol homeostasis (GO:0055090) | 3.94907301 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.93104999 |
| 39 | triglyceride catabolic process (GO:0019433) | 3.92629870 |
| 40 | regulation of digestive system process (GO:0044058) | 3.85011875 |
| 41 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.75138538 |
| 42 | positive regulation of steroid metabolic process (GO:0045940) | 3.64162796 |
| 43 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 3.60635446 |
| 44 | regulation of glutamate secretion (GO:0014048) | 3.58489851 |
| 45 | glycerolipid catabolic process (GO:0046503) | 3.56947999 |
| 46 | platelet dense granule organization (GO:0060155) | 3.55018901 |
| 47 | thrombin receptor signaling pathway (GO:0070493) | 3.52073069 |
| 48 | regulation of sterol transport (GO:0032371) | 3.48901205 |
| 49 | regulation of cholesterol transport (GO:0032374) | 3.48901205 |
| 50 | lipoprotein metabolic process (GO:0042157) | 3.41614242 |
| 51 | cholesterol homeostasis (GO:0042632) | 3.32501964 |
| 52 | negative regulation of amino acid transport (GO:0051956) | 3.30391746 |
| 53 | regulation of protein glycosylation (GO:0060049) | 3.29084697 |
| 54 | sterol homeostasis (GO:0055092) | 3.22285768 |
| 55 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.22211913 |
| 56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.19296776 |
| 57 | opioid receptor signaling pathway (GO:0038003) | 3.18093540 |
| 58 | blood coagulation, intrinsic pathway (GO:0007597) | 3.17026062 |
| 59 | negative regulation of norepinephrine secretion (GO:0010700) | 3.13915999 |
| 60 | regulation of lipoprotein metabolic process (GO:0050746) | 3.13257872 |
| 61 | angiogenesis involved in wound healing (GO:0060055) | 3.10988462 |
| 62 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.07063372 |
| 63 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.03647667 |
| 64 | response to pheromone (GO:0019236) | 2.95017790 |
| 65 | cardiac left ventricle morphogenesis (GO:0003214) | 2.94837415 |
| 66 | valine metabolic process (GO:0006573) | 2.92063933 |
| 67 | regulation of cholesterol storage (GO:0010885) | 2.91674900 |
| 68 | negative regulation of platelet activation (GO:0010544) | 2.90596559 |
| 69 | Golgi transport vesicle coating (GO:0048200) | 2.89155824 |
| 70 | COPI coating of Golgi vesicle (GO:0048205) | 2.89155824 |
| 71 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.88491251 |
| 72 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.87558654 |
| 73 | response to BMP (GO:0071772) | 2.84010865 |
| 74 | cellular response to BMP stimulus (GO:0071773) | 2.84010865 |
| 75 | regulation of coenzyme metabolic process (GO:0051196) | 2.81469045 |
| 76 | regulation of cofactor metabolic process (GO:0051193) | 2.81469045 |
| 77 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.80221976 |
| 78 | fatty acid elongation (GO:0030497) | 2.77959105 |
| 79 | platelet aggregation (GO:0070527) | 2.74910015 |
| 80 | positive regulation of muscle hypertrophy (GO:0014742) | 2.74558343 |
| 81 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.74558343 |
| 82 | auditory receptor cell differentiation (GO:0042491) | 2.73132250 |
| 83 | bile acid biosynthetic process (GO:0006699) | 2.72703345 |
| 84 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.72082796 |
| 85 | peptidyl-cysteine modification (GO:0018198) | 2.70785965 |
| 86 | multicellular organism reproduction (GO:0032504) | 2.69757789 |
| 87 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.67928274 |
| 88 | negative regulation of protein localization to cell surface (GO:2000009) | 2.67642821 |
| 89 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.67441316 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.66175813 |
| 91 | protein carboxylation (GO:0018214) | 2.66175813 |
| 92 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.61272672 |
| 93 | arginine catabolic process (GO:0006527) | 2.60995081 |
| 94 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.60902833 |
| 95 | neutrophil activation involved in immune response (GO:0002283) | 2.60342158 |
| 96 | adenosine metabolic process (GO:0046085) | 2.60192157 |
| 97 | negative regulation of heart rate (GO:0010459) | 2.56835618 |
| 98 | glycerophospholipid catabolic process (GO:0046475) | 2.56695100 |
| 99 | cellular ketone body metabolic process (GO:0046950) | 2.56334899 |
| 100 | glycoprotein catabolic process (GO:0006516) | 2.53486354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.46013205 |
| 2 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.82475728 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.79568158 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.68458362 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.59460299 |
| 6 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.36041588 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.34416897 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32854900 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.21744734 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.17770999 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.14362969 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.14321651 |
| 13 | P300_19829295_ChIP-Seq_ESCs_Human | 2.06064831 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.04446154 |
| 15 | EWS_26573619_Chip-Seq_HEK293_Human | 2.04311070 |
| 16 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.85618206 |
| 17 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.81068114 |
| 18 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.80956075 |
| 19 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.75443021 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75137561 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73168247 |
| 22 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.70261348 |
| 23 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.70261348 |
| 24 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.69166995 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67660858 |
| 26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.66844942 |
| 27 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.65364886 |
| 28 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.65364886 |
| 29 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.62065957 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59761586 |
| 31 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59064296 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.58992415 |
| 33 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.55359276 |
| 34 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.52746951 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52089169 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50611345 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.50096264 |
| 38 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.49293952 |
| 39 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48865065 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.45995175 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45740740 |
| 42 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43586855 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43525935 |
| 44 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43506702 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43064301 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42528717 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41147105 |
| 48 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.41088480 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.40696419 |
| 50 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.39452810 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.39406401 |
| 52 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39406401 |
| 53 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.37545610 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.36448003 |
| 55 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.33896544 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32036290 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31870675 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29840778 |
| 59 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28749901 |
| 60 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27552659 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27551693 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26355143 |
| 63 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.24958108 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21933179 |
| 65 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20385873 |
| 66 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19304522 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18727697 |
| 68 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17602233 |
| 69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17112536 |
| 70 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15951404 |
| 71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14881011 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14777981 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13929624 |
| 74 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.13432657 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11173883 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10879452 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08999749 |
| 78 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08348644 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07129917 |
| 80 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.06426415 |
| 81 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.06413241 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06006055 |
| 83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05787302 |
| 84 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05641752 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05512538 |
| 86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04547436 |
| 87 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03458097 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03273574 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03273574 |
| 90 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02313533 |
| 91 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01504766 |
| 92 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.00893120 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00562419 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00360934 |
| 95 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99818722 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99422387 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99392696 |
| 98 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99318086 |
| 99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99015614 |
| 100 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98863438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 7.25152159 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 5.12980886 |
| 3 | MP0005464_abnormal_platelet_physiology | 4.88202477 |
| 4 | MP0006292_abnormal_olfactory_placode | 4.11516698 |
| 5 | MP0008004_abnormal_stomach_pH | 3.53255924 |
| 6 | MP0005367_renal/urinary_system_phenotyp | 3.46375561 |
| 7 | MP0000516_abnormal_urinary_system | 3.46375561 |
| 8 | MP0009840_abnormal_foam_cell | 3.33667720 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.31715987 |
| 10 | MP0001986_abnormal_taste_sensitivity | 3.22158104 |
| 11 | MP0002254_reproductive_system_inflammat | 2.96478412 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.71541894 |
| 13 | MP0005084_abnormal_gallbladder_morpholo | 2.55087761 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.40289421 |
| 15 | MP0005410_abnormal_fertilization | 2.28279856 |
| 16 | MP0000537_abnormal_urethra_morphology | 2.12987482 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.08638458 |
| 18 | MP0004272_abnormal_basement_membrane | 2.08141039 |
| 19 | MP0003385_abnormal_body_wall | 1.90053982 |
| 20 | MP0003315_abnormal_perineum_morphology | 1.84924561 |
| 21 | MP0003890_abnormal_embryonic-extraembry | 1.83200891 |
| 22 | MP0005365_abnormal_bile_salt | 1.72505635 |
| 23 | MP0000639_abnormal_adrenal_gland | 1.71184327 |
| 24 | MP0001293_anophthalmia | 1.69875621 |
| 25 | MP0003941_abnormal_skin_development | 1.69568926 |
| 26 | MP0003136_yellow_coat_color | 1.61599751 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.61423006 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.58707196 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.42084205 |
| 30 | MP0005085_abnormal_gallbladder_physiolo | 1.28261851 |
| 31 | MP0002736_abnormal_nociception_after | 1.27072609 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.25243642 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.21826658 |
| 34 | MP0002938_white_spotting | 1.16115076 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.11582507 |
| 36 | MP0003724_increased_susceptibility_to | 1.11066037 |
| 37 | MP0002277_abnormal_respiratory_mucosa | 1.07487043 |
| 38 | MP0009697_abnormal_copulation | 1.06615406 |
| 39 | MP0003718_maternal_effect | 1.05636129 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.04548391 |
| 41 | MP0002168_other_aberrant_phenotype | 1.03473790 |
| 42 | MP0005395_other_phenotype | 1.02900119 |
| 43 | MP0004133_heterotaxia | 1.01432759 |
| 44 | MP0004484_altered_response_of | 1.00683017 |
| 45 | MP0003567_abnormal_fetal_cardiomyocyte | 1.00339798 |
| 46 | MP0005408_hypopigmentation | 1.00297394 |
| 47 | MP0004130_abnormal_muscle_cell | 0.99874516 |
| 48 | MP0001915_intracranial_hemorrhage | 0.99123988 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94549719 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 0.93765651 |
| 51 | MP0004084_abnormal_cardiac_muscle | 0.93496676 |
| 52 | MP0002233_abnormal_nose_morphology | 0.91984629 |
| 53 | MP0003195_calcinosis | 0.89530564 |
| 54 | MP0003137_abnormal_impulse_conducting | 0.85371833 |
| 55 | MP0003938_abnormal_ear_development | 0.84978716 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 0.83536632 |
| 57 | MP0002972_abnormal_cardiac_muscle | 0.79303358 |
| 58 | MP0005083_abnormal_biliary_tract | 0.78887978 |
| 59 | MP0003868_abnormal_feces_composition | 0.78090824 |
| 60 | MP0005332_abnormal_amino_acid | 0.77674476 |
| 61 | MP0003122_maternal_imprinting | 0.77415583 |
| 62 | MP0000778_abnormal_nervous_system | 0.76328734 |
| 63 | MP0001697_abnormal_embryo_size | 0.76098177 |
| 64 | MP0000604_amyloidosis | 0.74731605 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 0.74626102 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 0.74472452 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 0.74468006 |
| 68 | MP0002128_abnormal_blood_circulation | 0.73352547 |
| 69 | MP0003186_abnormal_redox_activity | 0.71970072 |
| 70 | MP0008789_abnormal_olfactory_epithelium | 0.70600489 |
| 71 | MP0000230_abnormal_systemic_arterial | 0.70261570 |
| 72 | MP0000372_irregular_coat_pigmentation | 0.68450570 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 0.65683961 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 0.64964937 |
| 75 | MP0004085_abnormal_heartbeat | 0.64195799 |
| 76 | MP0004883_abnormal_blood_vessel | 0.63769228 |
| 77 | MP0005646_abnormal_pituitary_gland | 0.63552704 |
| 78 | MP0003119_abnormal_digestive_system | 0.63446171 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.63165334 |
| 80 | MP0003937_abnormal_limbs/digits/tail_de | 0.63137206 |
| 81 | MP0001119_abnormal_female_reproductive | 0.62768034 |
| 82 | MP0000249_abnormal_blood_vessel | 0.62422105 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.61082266 |
| 84 | MP0005394_taste/olfaction_phenotype | 0.61074176 |
| 85 | MP0005499_abnormal_olfactory_system | 0.61074176 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.60443123 |
| 87 | MP0008872_abnormal_physiological_respon | 0.59913614 |
| 88 | MP0000566_synostosis | 0.59763844 |
| 89 | MP0009384_cardiac_valve_regurgitation | 0.53238804 |
| 90 | MP0005620_abnormal_muscle_contractility | 0.52274772 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 0.50987785 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.50200997 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.49287348 |
| 94 | MP0005623_abnormal_meninges_morphology | 0.48727349 |
| 95 | MP0005310_abnormal_salivary_gland | 0.48509423 |
| 96 | MP0001544_abnormal_cardiovascular_syste | 0.48313375 |
| 97 | MP0005385_cardiovascular_system_phenoty | 0.48313375 |
| 98 | MP0002084_abnormal_developmental_patter | 0.47700453 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.47435899 |
| 100 | MP0002088_abnormal_embryonic_growth/wei | 0.47365649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperlipoproteinemia (HP:0010980) | 5.87470573 |
| 2 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 5.79976999 |
| 3 | Hypoalphalipoproteinemia (HP:0003233) | 5.10290750 |
| 4 | Spontaneous abortion (HP:0005268) | 4.86808429 |
| 5 | Menorrhagia (HP:0000132) | 4.80098320 |
| 6 | Gingival bleeding (HP:0000225) | 4.70032046 |
| 7 | Hypolipoproteinemia (HP:0010981) | 4.65111515 |
| 8 | Prolonged bleeding time (HP:0003010) | 4.61194620 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 4.58636377 |
| 10 | Epidermoid cyst (HP:0200040) | 4.34797783 |
| 11 | Hyperglycinemia (HP:0002154) | 4.26577094 |
| 12 | Increased mean platelet volume (HP:0011877) | 4.25102385 |
| 13 | Renal cortical cysts (HP:0000803) | 4.19340564 |
| 14 | Nausea (HP:0002018) | 4.14014904 |
| 15 | Petechiae (HP:0000967) | 3.92850447 |
| 16 | Myocardial infarction (HP:0001658) | 3.92311625 |
| 17 | Xanthomatosis (HP:0000991) | 3.89667686 |
| 18 | Abnormal platelet volume (HP:0011876) | 3.81017565 |
| 19 | Epistaxis (HP:0000421) | 3.80210929 |
| 20 | Acanthocytosis (HP:0001927) | 3.77187981 |
| 21 | Abnormality of alanine metabolism (HP:0010916) | 3.65506876 |
| 22 | Hyperalaninemia (HP:0003348) | 3.65506876 |
| 23 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.65506876 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 3.56175377 |
| 25 | B lymphocytopenia (HP:0010976) | 3.46021491 |
| 26 | Retinal atrophy (HP:0001105) | 3.39814134 |
| 27 | Methylmalonic acidemia (HP:0002912) | 3.22566395 |
| 28 | Poikilocytosis (HP:0004447) | 3.19000778 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.09857469 |
| 30 | Ectropion (HP:0000656) | 2.91116001 |
| 31 | Intestinal atresia (HP:0011100) | 2.89447345 |
| 32 | Purpura (HP:0000979) | 2.87352971 |
| 33 | Proximal tubulopathy (HP:0000114) | 2.69748173 |
| 34 | Joint swelling (HP:0001386) | 2.66557242 |
| 35 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.64929569 |
| 36 | Amyloidosis (HP:0011034) | 2.55329457 |
| 37 | Abnormality of vitamin B metabolism (HP:0004340) | 2.50613003 |
| 38 | Septo-optic dysplasia (HP:0100842) | 2.47544044 |
| 39 | Joint hemorrhage (HP:0005261) | 2.46864274 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 2.46418119 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.45793327 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.45621571 |
| 43 | 3-Methylglutaconic aciduria (HP:0003535) | 2.38670175 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.29692222 |
| 45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.29692222 |
| 46 | Paralysis (HP:0003470) | 2.27423881 |
| 47 | Abnormality of the renal cortex (HP:0011035) | 2.25889164 |
| 48 | Growth hormone deficiency (HP:0000824) | 2.24230632 |
| 49 | Gonadal dysgenesis (HP:0000133) | 2.21170491 |
| 50 | Hypophosphatemic rickets (HP:0004912) | 2.20973372 |
| 51 | Papillary thyroid carcinoma (HP:0002895) | 2.20127154 |
| 52 | Abnormal platelet function (HP:0011869) | 2.17752987 |
| 53 | Impaired platelet aggregation (HP:0003540) | 2.17752987 |
| 54 | Methylmalonic aciduria (HP:0012120) | 2.17657047 |
| 55 | Chorioretinal atrophy (HP:0000533) | 2.14650094 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.11921857 |
| 57 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.11116216 |
| 58 | Absent/shortened dynein arms (HP:0200106) | 2.11116216 |
| 59 | Glycosuria (HP:0003076) | 2.10450472 |
| 60 | Abnormality of urine glucose concentration (HP:0011016) | 2.10450472 |
| 61 | Abnormality of the ischium (HP:0003174) | 2.08434758 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.08311205 |
| 63 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.06474158 |
| 64 | Chronic hepatic failure (HP:0100626) | 2.04860745 |
| 65 | Febrile seizures (HP:0002373) | 2.03876196 |
| 66 | Disproportionate short-trunk short stature (HP:0003521) | 2.02753471 |
| 67 | Abnormal auditory evoked potentials (HP:0006958) | 2.01377133 |
| 68 | Male infertility (HP:0003251) | 2.00583070 |
| 69 | Polyphagia (HP:0002591) | 2.00509782 |
| 70 | Spastic paraparesis (HP:0002313) | 2.00461413 |
| 71 | Acute encephalopathy (HP:0006846) | 2.00169610 |
| 72 | Hyperglycinuria (HP:0003108) | 1.98055940 |
| 73 | Cupped ear (HP:0000378) | 1.95312771 |
| 74 | Abnormality of vitamin metabolism (HP:0100508) | 1.94955407 |
| 75 | Rhinitis (HP:0012384) | 1.93851579 |
| 76 | Abnormal pancreas size (HP:0012094) | 1.92716072 |
| 77 | Facial diplegia (HP:0001349) | 1.92708381 |
| 78 | Follicular hyperkeratosis (HP:0007502) | 1.91342023 |
| 79 | Severe Myopia (HP:0011003) | 1.89023901 |
| 80 | Hyperammonemia (HP:0001987) | 1.88587201 |
| 81 | Intrahepatic cholestasis (HP:0001406) | 1.84256765 |
| 82 | Optic nerve hypoplasia (HP:0000609) | 1.81663095 |
| 83 | Dysautonomia (HP:0002459) | 1.81153204 |
| 84 | Abnormal ciliary motility (HP:0012262) | 1.80385092 |
| 85 | Decreased muscle mass (HP:0003199) | 1.78991987 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 1.78505392 |
| 87 | Hyperventilation (HP:0002883) | 1.78369848 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.77919034 |
| 89 | Concave nail (HP:0001598) | 1.76953956 |
| 90 | Curly hair (HP:0002212) | 1.75218403 |
| 91 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.75070141 |
| 92 | Hypoglycemic coma (HP:0001325) | 1.74559819 |
| 93 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.74422887 |
| 94 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.74422887 |
| 95 | Abnormal pupillary function (HP:0007686) | 1.72164198 |
| 96 | Abnormality of the nasal septum (HP:0000419) | 1.66015346 |
| 97 | Thyroid carcinoma (HP:0002890) | 1.65824357 |
| 98 | Absent eyebrow (HP:0002223) | 1.65658827 |
| 99 | Spontaneous hematomas (HP:0007420) | 1.63860904 |
| 100 | Bifid tongue (HP:0010297) | 1.62546996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 4.92360404 |
| 2 | ADRBK2 | 4.21108433 |
| 3 | MST4 | 3.92859827 |
| 4 | TRIM28 | 3.49207591 |
| 5 | ZAK | 3.48849092 |
| 6 | SIK3 | 3.30518510 |
| 7 | TXK | 3.16064365 |
| 8 | WNK3 | 3.14468224 |
| 9 | TNIK | 2.67558706 |
| 10 | MAPK13 | 2.33290946 |
| 11 | SCYL2 | 2.33174813 |
| 12 | PKN1 | 2.19031350 |
| 13 | PAK3 | 2.07899964 |
| 14 | PBK | 1.93823675 |
| 15 | MAP4K1 | 1.87951980 |
| 16 | TLK1 | 1.67361089 |
| 17 | PIK3CG | 1.64487683 |
| 18 | MYLK | 1.64399238 |
| 19 | AKT3 | 1.59918194 |
| 20 | NUAK1 | 1.55727956 |
| 21 | TYRO3 | 1.41270021 |
| 22 | BMPR1B | 1.33398207 |
| 23 | BRSK2 | 1.33122161 |
| 24 | EIF2AK3 | 1.22286015 |
| 25 | EIF2AK1 | 1.21907722 |
| 26 | BMX | 1.21351931 |
| 27 | MKNK2 | 1.14923095 |
| 28 | BRD4 | 1.13178479 |
| 29 | NLK | 1.12812861 |
| 30 | PTK2B | 1.12587503 |
| 31 | BCR | 1.09737497 |
| 32 | ACVR1B | 1.08999569 |
| 33 | TEC | 1.07688581 |
| 34 | MKNK1 | 1.07099819 |
| 35 | NME1 | 1.06537007 |
| 36 | FGFR2 | 1.06239655 |
| 37 | STK3 | 1.05110968 |
| 38 | FGFR3 | 1.03926441 |
| 39 | WNK4 | 1.02755970 |
| 40 | PLK2 | 0.95953778 |
| 41 | GRK1 | 0.94963511 |
| 42 | NEK9 | 0.94231374 |
| 43 | PNCK | 0.90964737 |
| 44 | STK39 | 0.89679107 |
| 45 | TAF1 | 0.88889638 |
| 46 | LATS1 | 0.85897142 |
| 47 | BCKDK | 0.85143036 |
| 48 | MARK3 | 0.83113612 |
| 49 | KSR1 | 0.75518626 |
| 50 | PLK3 | 0.73204930 |
| 51 | PRKG1 | 0.72030185 |
| 52 | ROCK1 | 0.71084834 |
| 53 | ZAP70 | 0.69853349 |
| 54 | TESK1 | 0.67764832 |
| 55 | FGFR4 | 0.64211625 |
| 56 | SRPK1 | 0.62725883 |
| 57 | TESK2 | 0.60198113 |
| 58 | MAP3K12 | 0.58454796 |
| 59 | GRK5 | 0.58037174 |
| 60 | PRKCE | 0.57054656 |
| 61 | FRK | 0.54084772 |
| 62 | NTRK2 | 0.53166995 |
| 63 | BTK | 0.51447423 |
| 64 | FGR | 0.50089564 |
| 65 | CSF1R | 0.48870213 |
| 66 | SYK | 0.48560898 |
| 67 | STK4 | 0.47029941 |
| 68 | PRKACG | 0.46382911 |
| 69 | MINK1 | 0.45576962 |
| 70 | PRKACB | 0.40072443 |
| 71 | DYRK1A | 0.39819510 |
| 72 | HCK | 0.39008332 |
| 73 | LIMK1 | 0.37460109 |
| 74 | NEK1 | 0.37436939 |
| 75 | PDGFRB | 0.37045793 |
| 76 | CAMK2A | 0.34967509 |
| 77 | LMTK2 | 0.34298009 |
| 78 | DAPK3 | 0.33259909 |
| 79 | PRKCG | 0.32104723 |
| 80 | MAP3K10 | 0.32103623 |
| 81 | MELK | 0.31301697 |
| 82 | PRKCB | 0.30994320 |
| 83 | PRKACA | 0.30526676 |
| 84 | ADRBK1 | 0.24917741 |
| 85 | STK24 | 0.24328280 |
| 86 | EPHB2 | 0.23525181 |
| 87 | SGK2 | 0.23086046 |
| 88 | CSNK1D | 0.22743757 |
| 89 | PRKCI | 0.22467318 |
| 90 | ERBB4 | 0.22377942 |
| 91 | ILK | 0.21950583 |
| 92 | PRKCA | 0.21109214 |
| 93 | PAK1 | 0.20785577 |
| 94 | INSR | 0.20574738 |
| 95 | WEE1 | 0.20238328 |
| 96 | PAK2 | 0.20204759 |
| 97 | CSNK2A1 | 0.20127768 |
| 98 | PRKD1 | 0.19823926 |
| 99 | FES | 0.19046405 |
| 100 | PDGFRA | 0.18902732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.74635064 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.67593160 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.17651870 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.14109265 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.06318722 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.57817112 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.57447192 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.50869476 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.39559755 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.28751249 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.26842630 |
| 12 | Platelet activation_Homo sapiens_hsa04611 | 2.25448815 |
| 13 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.05997756 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.94825621 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.91863768 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.91680491 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.89820874 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79592221 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.77504000 |
| 20 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.67226027 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.66398285 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65455303 |
| 23 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.63258485 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.58186686 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51026026 |
| 26 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.47483487 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42231769 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39211835 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.35093585 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32526175 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26591125 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24280832 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23906123 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.23071604 |
| 35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21424167 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19382265 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18313657 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16996550 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.15488982 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14611220 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10839006 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02752456 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99291154 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99101808 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96807534 |
| 46 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.93159294 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92736175 |
| 48 | Alcoholism_Homo sapiens_hsa05034 | 0.92528422 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91496991 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91411482 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88898917 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87851382 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86532793 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85300124 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81260141 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77612501 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76854287 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75740637 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73776676 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69250959 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67712798 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.67304348 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66855171 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62901668 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61472021 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61445368 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60490930 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.58342216 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55560809 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54395113 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48803746 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.48284446 |
| 73 | Proteasome_Homo sapiens_hsa03050 | 0.46021800 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44328013 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42538423 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42208863 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40916555 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40283033 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28774612 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.28717932 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28675233 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.27089933 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.27056219 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26299889 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26087684 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25770876 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.24878654 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23484575 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22701541 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22103483 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21753032 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.20990771 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19887958 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.19670552 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.18512149 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17551203 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.16710113 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.15561570 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15119879 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.14576913 |

